Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for Travere Therapeutics stock have an average target of 33.31, with a low estimate of 20 and a high estimate of 47. The average target predicts an increase of 59.07% from the current stock price of 20.94.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$33.31	$31	$47
Change	-4.49%	+59.07%	+48.04%	+124.45%

Analyst Ratings

The average analyst rating for Travere Therapeutics stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	4	4	4	4	5	5
Buy	6	6	8	8	7	7
Hold	3	2	1	1	1	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	12	13	13	13	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Laura Chico Wedbush	Wedbush	Buy Reiterates $30	Buy	Reiterates	$30	+43.27%	May 2, 2025
Alex Thompson Stifel	Stifel	Hold Maintains $22 → $23	Hold	Maintains	$22 → $23	+9.84%	May 2, 2025
Prakhar Agrawal Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Apr 23, 2025
Vamil Divan Guggenheim	Guggenheim	Strong Buy Reiterates $47	Strong Buy	Reiterates	$47	+124.45%	Apr 14, 2025
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $45 → $47	Strong Buy	Maintains	$45 → $47	+124.45%	Apr 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

392.45M

Increased by 68.31%

from 233.18M

Revenue Next Year

610.85M

Increased by 55.65%

from 392.45M

EPS This Year

-1.47

from -4.08

EPS Next Year

1.01

from -1.47

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	198.32M	131.84M	109.46M	145.24M	233.18M	392.45M	610.85M	712.80M
Revenue Growth	13.11%	-33.52%	-16.97%	32.69%	60.55%	68.31%	55.65%	16.69%
EPS	-3.56	-3.01	-4.37	-1.50	-4.08	-1.47	1.01	1.74
EPS Growth	-	-	-	-	-	-	-	72.61%
Forward PE	-	-	-	-	-	-	20.78	12.04
No. Analysts	-	-	-	-	-	17	16	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	461.9M	840.2M	849.4M
Avg	392.5M	610.9M	712.8M
Low	324.5M	433.7M	575.8M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	98.1%	114.1%	39.1%
Avg	68.3%	55.7%	16.7%
Low	39.2%	10.5%	-5.7%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.59	3.47	3.39
Avg	-1.47	1.01	1.74
Low	-2.39	-0.96	0.31

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	236.6%
Avg	-	-	72.6%
Low	-	-	-68.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.